E. Shyam P. Reddy: New study by Northwestern Medicine Canning Thoracic Institute revealed a connection between COVID-19 and cancer regression
E. Shyam P. Reddy, Professor and Director of the Cancer Biology Program in the Department of OB/GYN at the Morehouse School of Medicine, shared a post on LinkedIn:
“A new study led by scientists from the Northwestern Medicine Canning Thoracic Institute and published in the Journal of Clinical Investigation has revealed a connection between COVID-19 infection and cancer regression.
The team’s discovery could pave the way for novel cancer treatments.
In an unexpected twist, the scientists observed that the RNA from the SARS-CoV-2 virus—responsible for COVID-19—triggered the development of a unique type of immune cell with anti-cancer properties.
These cells, dubbed ‘inducible nonclassical monocytes (I-NCMs),’ were found to attack cancer cells and could potentially be harnessed to treat cancers that are resistant to current therapies.
These findings possibly explain the mechanism behind the reported regression of certain cancers following COVID-19 infection.
‘This discovery opens up a new avenue for cancer treatment,’ said Ankit Bharat, chief of Thoracic Surgery, the Harold L. and Margaret N. Method Professor of Surgery and director of the Canning Thoracic Institute, who was senior author of the study.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023